Antipsychotics and Gradual Dose Reduction
Overview: To continue or not to continue? In an effort to enhance the quality of life for post-acute care residents, the Centers for Medicare and Medicaid
To continue or not to continue? In an effort to enhance the quality of life for post-acute care residents, the Centers for Medicare and Medicaid Services (CMS) in recent years has adopted regulatory guidelines that target the use of psychotropic medications. These regulations have encouraged clinicians to minimize the use of “unnecessary medications” in post-acute care settings and, whenever possible, rely on non-pharmacological interventions to treat mood and behavioral issues. Meeting these expectations can be challenging for post-acute facilities – especially those with limited access to mental health professionals – and can lead to survey problems.
CE’s: NHA & SW
Anna Meyer, Clinical Pharmacy Supervisor, Avera Long-Term Care Pharmacy
Anna Meyer, PharmD is the Clinical Pharmacy Supervisor for the Avera Long-Term Care Pharmacy and has been a consultant pharmacist for over 5 years. In her role she is responsible for developing clinical and educational initiatives designed to optimize drug therapy in the elderly in both the nursing home and assisted living settings. Anna is an active member of the Statewide Antibiotic Stewardship Collaborative in South Dakota and Minnesota and also serves as a preceptor with the South Dakota State University (SDSU) College of Pharmacy and as adjunct associate professor in the Department of Pharmacy Practice in the College of Pharmacy and Allied Health Professions.
Free for SDAHO Members: Sign in to the Member Portal and go to the Education Portal to register.
$49 for Non-Members: Click here to register.
(Thursday) 11:00 am - 12:00 pm CST